Skip to main navigation Skip to search Skip to main content

Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology

  • Al B. Benson
  • , Alan P. Venook
  • , Mahmoud M. Al-Hawary
  • , Lynette Cederquist
  • , Yi Jen Chen
  • , Kristen K. Ciombor
  • , Stacey Cohen
  • , Harry S. Cooper
  • , Dustin Deming
  • , Paul F. Engstrom
  • , Jean L. Grem
  • , Axel Grothey
  • , Howard S. Hochster
  • , Sarah Hoffe
  • , Steven Hunt
  • , Ahmed Kamel
  • , Natalie Kirilcuk
  • , Smitha Krishnamurthi
  • , Wells A. Messersmith
  • , Jeffrey Meyerhardt
  • Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass
  • Northwestern University
  • University of California at San Francisco
  • University of Michigan, Ann Arbor
  • University of California at San Diego
  • City of Hope National Medical Center
  • Vanderbilt University
  • Seattle Cancer Care Alliance
  • University of Wisconsin-Madison
  • Fox Chase Cancer Center
  • University of Nebraska Medical Center
  • Mayo Clinic
  • Yale University
  • University of South Florida
  • Washington University St. Louis
  • University of Alabama at Birmingham
  • Stanford University
  • Case Western Reserve University
  • University of Colorado Cancer Center
  • Dana-Farber Cancer Institute
  • Roswell Park Comprehensive Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • University of Utah
  • University of Tennessee Health Science Center
  • University of Texas MD Anderson Cancer Center
  • Johns Hopkins University
  • Duke University
  • Ohio State University

Research output: Contribution to journal › Review article › peer-review

463 Scopus citations

Abstract

The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.

Original languageEnglish
Pages (from-to)852-871
Number of pages20
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume16
Issue number7
DOIs
StatePublished - Jul 1 2018

Keywords

  • Anal Canal/pathology
  • Antineoplastic Combined Chemotherapy Protocols/standards
  • Anus Neoplasms/diagnosis
  • Biopsy
  • Carcinoma, Squamous Cell/diagnosis
  • Chemoradiotherapy/methods
  • Colostomy/standards
  • Disease-Free Survival
  • Humans
  • Medical Oncology/standards
  • Neoplasm Recurrence, Local/diagnosis
  • Patient Care Team/standards
  • Randomized Controlled Trials as Topic
  • Societies, Medical/standards
  • United States/epidemiology

Fingerprint

Dive into the research topics of 'Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology'. Together they form a unique fingerprint.

Cite this